Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
Tag: AbbVie
AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai
New AA (Allergan Aesthetics) Signature™ multimodal treatment approach to be presented at AMWC Dubai following successful launch in 25 countries so far this year. Experts to explore the paradigm shift in medical aesthetics and decode […]
